Avicenna continues to grow by welcoming Alexion among its members
The Avicenna Alliance is proud to announce the newest addition to its list of members: Alexion!
Alexion is a global biopharmaceutical company with more than 25 years of experience focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. Our mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all that we do. We continue to deepen our understanding of rare disease, innovating and evolving into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives.
More information about Alexion can be found here.